Effectiveness of Coenzyme Q10 and Probiotics in Periodontal Therapy During Pregnancy

Last updated: February 19, 2026
Sponsor: University of Pavia
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pregnancy

Periodontitis

Treatment

Limosilactobacillus reuteri Prodentis®

Coenzyme Q10 Toothpaste

Clinical Study ID

NCT07029360
2025-Q10PROBIOPREG
  • Ages > 18
  • Female

Study Summary

This randomized controlled clinical trial aims to evaluate the effectiveness of adjunctive coenzyme Q10 and probiotic supplementation (Limosilactobacillus reuteri Prodentis®) in improving periodontal health in pregnant women undergoing non-surgical periodontal therapy. Forty participants will be randomly assigned to two groups: the test group will receive professional oral hygiene every three months along with a coenzyme Q10-based toothpaste and daily probiotic supplementation; the control group will follow the same protocol without probiotics. The primary outcome is the reduction of the Plaque Index (PI), while secondary outcomes include Bleeding on Probing (BoP), Probing Pocket Depth (PPD), Clinical Attachment Level (CAL), gingival inflammation (MGI, PMGI), plaque distribution (PCR%, API), and gingival recession (R). The study duration is 6 months. The goal is to assess whether this combined therapy can promote a balanced oral microbiota and enhance periodontal health during pregnancy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Pregnant women between the 4th and 8th month of gestation

  • Age ≥ 18 years

  • Able to understand and communicate in Italian and/or English

  • Willing to provide written informed consent

  • Good compliance and willingness to follow study instructions

Exclusion

Exclusion Criteria:

  • Presence of cardiac pacemakers

  • Diagnosed psychological, neurological, or psychiatric disorders

  • Ongoing oncological therapy

  • Use of bisphosphonates within the last 12 months

  • Poor motivation or low compliance

  • Substance abuse (drugs or alcohol) or lifestyle incompatible with study requirements

Study Design

Total Participants: 40
Treatment Group(s): 2
Primary Treatment: Limosilactobacillus reuteri Prodentis®
Phase:
Study Start date:
July 01, 2025
Estimated Completion Date:
June 10, 2026

Connect with a study center

  • Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia

    Pavia, Lombardy 27100
    Italy

    Site Not Available

  • Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia

    Pavia 3171366, Lombardy 3174618 27100
    Italy

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.